Canada - English - Health Canada

sandoz canada incorporated - clindamycin (clindamycin phosphate) - solution - 6mg - clindamycin (clindamycin phosphate) 6mg - lincomycins

Canada - English - Health Canada

sandoz canada incorporated - clindamycin (clindamycin phosphate) - solution - 12mg - clindamycin (clindamycin phosphate) 12mg - lincomycins

Canada - English - Health Canada

sandoz canada incorporated - clindamycin (clindamycin phosphate) - solution - 18mg - clindamycin (clindamycin phosphate) 18mg - lincomycins

Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - clindamycin phosphate eqv clindamycin - injection - 150 mg/ml - clindamycin phosphate eqv clindamycin 150 mg/ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance pharmaceuticals ltd - chloroquine phosphate - oral tablet - 250mg

New Zealand - English - Medsafe (Medicines Safety Authority)

max health limited - clindamycin phosphate 178.23 mg/ml equivalent to clindamycin 150mg/ml - solution for injection - 300 mg/2ml - active: clindamycin phosphate 178.23 mg/ml equivalent to clindamycin 150mg/ml excipient: benzyl alcohol disodium edetate nitrogen sodium hydroxide water for injection - clindamycin phosphate has been shown to be effective in the treatment of the following infections when caused by susceptible anaerobic bacteria or susceptible strains of gram positive bacteria such as streptococci, staphylococci and pneumococci: 1. upper respiratory infections including tonsillitis, pharyngitis, sinusitis, otitis media and scarlet fever.

New Zealand - English - Medsafe (Medicines Safety Authority)

max health limited - clindamycin phosphate 178.23 mg/ml equivalent to clindamycin 150mg/ml - solution for injection - 600 mg/4ml - active: clindamycin phosphate 178.23 mg/ml equivalent to clindamycin 150mg/ml excipient: benzyl alcohol disodium edetate nitrogen sodium hydroxide water for injection - clindamycin phosphate has been shown to be effective in the treatment of the following infections when caused by susceptible anaerobic bacteria or susceptible strains of gram positive bacteria such as streptococci, staphylococci and pneumococci: 1. upper respiratory infections including tonsillitis, pharyngitis, sinusitis, otitis media and scarlet fever.

Bangladesh - English - DGDA (Directorate General of Drug Administration)

advanced chemical industries limited - primaquine - tablet - 15 mg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

globe pharmaceuticals ltd. - primaquine - tablet - 15 mg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

hudson pharmaceuticals ltd. - primaquine - tablet - 15 mg